NTN4 and nonpapillary renal cell carcinoma: We assessed cell viability using the CCK-8 assay and found that NTN4 overexpression reduced the metabolic activity of ccRCC cells from day 3 compared with the pc-Vector group (p < 0.01) (Figure 5C), indicating that NTN4 slowed ccRCC cell growth.